Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Sales $ 2,605,158 $ 60,228 $ 3,220,557 $ 474,546
Cost of sales (210,437) (80,995) (650,003) (571,621)
Gross profit (loss) 2,394,721 (20,767) 2,570,554 (97,075)
Operating Expenses        
Selling and marketing 100,870 110,687 336,081 160,686
General and administrative 1,370,870 859,967 3,934,500 3,342,240
Depreciation and amortization 35,758 45,906 103,680 138,409
Gain from insurance settlement (30,240) (30,240)
Total operating expenses 1,507,498 986,320 4,374,261 3,611,095
Income (Loss) From Operations 887,223 (1,007,087) (1,803,707) (3,708,170)
Other Expense (Income)        
Interest expense, net 49,646 72,459 88,209 193,595
Forgiveness of PPP Loan (242,486)
Gain on debt restructuring (130,421) (130,421)
Other income (87,500) (87,500)
Gains from foreign currency translation (6,130) (14,826) (34,991) (35,316)
Total other (income) expense (43,984) (72,788) (276,768) 27,858
Net Income (Loss) 931,207 (934,299) (1,526,939) (3,736,028)
Net loss attributable to non-controlling interest 45,086 32,838 142,647 128,355
Series B preferred stock dividends (178,094) (540,217)
Net Income (Loss) Attributable to Common Stockholders $ 976,293 $ (1,079,555) $ (1,384,292) $ (4,147,890)
Earnings (Loss) Per Common Share - Basic and Diluted        
Basic $ 0.11 $ (0.26) $ (0.18) $ (1.02)
Diluted $ 0.11 $ (0.26) $ (0.18) $ (1.02)
Shares used in computing earnings per share:        
Basic 8,658,395 4,110,303 7,530,833 4,049,059
Diluted 8,658,395 4,110,303 7,530,833 4,049,059